Death and Disability from Warfarin-Associated Intracranial and Extracranial Hemorrhages
Top Cited Papers
- 23 May 2007
- journal article
- research article
- Published by Elsevier in The American Journal of Medicine
- Vol. 120 (8), 700-705
- https://doi.org/10.1016/j.amjmed.2006.07.034
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Age and the Risk of Warfarin‐Associated Hemorrhage: The Anticoagulation and Risk Factors In Atrial Fibrillation StudyJournal of the American Geriatrics Society, 2006
- Avoiding Central Nervous System Bleeding During Antithrombotic TherapyStroke, 2005
- Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: Observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) StudyAmerican Heart Journal, 2005
- Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: observational study Commentary: Varied preferences reflect the reality of clinical practiceBMJ, 2001
- Adverse Outcomes and Predictors of Underuse of Antithrombotic Therapy in Medicare Beneficiaries With Chronic Atrial FibrillationStroke, 2000
- Apolipoprotein E Genotype and the Risk of Recurrent Lobar Intracerebral HemorrhageNew England Journal of Medicine, 2000
- Factors Associated With Ischemic Stroke During Aspirin Therapy in Atrial FibrillationStroke, 1999
- Optimal Oral Anticoagulant Therapy in Patients with Nonrheumatic Atrial Fibrillation and Recent Cerebral IschemiaNew England Journal of Medicine, 1995
- Atrial fibrillation as an independent risk factor for stroke: the Framingham Study.Stroke, 1991
- A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project--1981-86. 2. Incidence, case fatality rates and overall outcome at one year of cerebral infarction, primary intracerebral and subarachnoid haemorrhage.Journal of Neurology, Neurosurgery & Psychiatry, 1990